Skip to content

Infinity Pharmaceuticals, Inc.

CIK 0001113148

← back to feed
Revenue (TTM)
$2.71M
+39.6% YoY Q2 Aug 2023
Net Income (TTM)
−$43.7M
+2.0% YoY Q2 Aug 2023
EPS Diluted (TTM)
−$0.48
+5.7% YoY Q2 Aug 2023
Gross Margin
—
Q2 Aug 2023
Operating Margin
-1,641.8%
Q2 Aug 2023
Net Margin
-1,611.5%
Q2 Aug 2023
Free Cash Flow (TTM)
−$51.39M
Q2 Aug 2023
Cash
$17.75M
Q2 Aug 2023
Total Debt
—
Q2 Aug 2023
Shares Outstanding
90.76M sh
Q2 Aug 2023

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings